Contract for Linear - A Phase 1, Randomised, Double-Blind, Placebo-Controlled, Ascending Single- and Repeat-Dose Study of the Safety, Tolerability and Pharmacokinetics of Orally Administered PRN473

Project Details

StatusFinished
Effective start/end date17/06/131/05/14

Funding

  • Clinical Network Services CNS Pty Ltd: A$265,697.00